Skip to main content

Healhty

4
Pipeline Programs
4
Companies
4
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
4
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

4 companies ranked by most advanced pipeline stage

Viatris
ViatrisCANONSBURG, PA
1 program
1
Amlodipine and Benazepril HCl Capsules 10 mg/20 mgPhase 11 trial
Active Trials
NCT00649402Completed64Est. Jun 2004
Biocorp
BiocorpFrance - Issoire
1 program
1
BGM1812Phase 1
BrightGene
BrightGeneChina - Suzhou
1 program
1
BGM1812Phase 12 trials
Active Trials
NCT07918625Not Yet Recruiting160Est. Aug 2027
NCT07224399Active Not Recruiting60Est. Oct 2026
WD Pharmaceutical
WD PharmaceuticalChina - Shanghai
1 program
1
Carbidopa and Levodopa Controlled-Release TabletsPhase 11 trial
Active Trials
NCT07442591Completed12Est. Apr 2026

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
BrightGeneBGM1812
WD PharmaceuticalCarbidopa and Levodopa Controlled-Release Tablets
BrightGeneBGM1812
ViatrisAmlodipine and Benazepril HCl Capsules 10 mg/20 mg

Clinical Trials (4)

Total enrollment: 296 patients across 4 trials

NCT07918625BrightGeneBGM1812

A Study to Evaluate Efficacy and Safety of BGM1812 Injection in Overweight or Obese Participants Without Diabetes

Start: Nov 2026Est. completion: Aug 2027160 patients
Phase 2Not Yet Recruiting
NCT07442591WD PharmaceuticalCarbidopa and Levodopa Controlled-Release Tablets

A Study to Assess Effect of Dosing Intervals on Multiple-Dose Pharmacokinetics of WD-1603 Taken Before Meals in Healthy Participants

Start: Mar 2026Est. completion: Apr 202612 patients
Phase 1Completed
NCT07224399BrightGeneBGM1812

Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of BGM1812 Injection Following Single and Multiple Subcutaneous Administration in Normal to Overweight or Obese But Otherwise Healthy Men and Women

Start: Oct 2025Est. completion: Oct 202660 patients
Phase 1Active Not Recruiting
NCT00649402ViatrisAmlodipine and Benazepril HCl Capsules 10 mg/20 mg

Fed Study of Amlodipine and Benazepril HCl Capsules 10 mg/20 mg to Lotrel® Capsules 10 mg/20 mg

Start: May 2004Est. completion: Jun 200464 patients
Phase 1Completed

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

4 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.